Open AccessHigh SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Author(s) -
Philip Bruggmann,
Oliver Senn,
Anja Frei,
Milo A. Puhan,
Jan Fehr,
Luis Falcato
Publication year - 2022
Publication title -
swiss medical weekly
Language(s) - English
Resource type - Journals
eISSN - 1424-7860
pISSN - 1424-3997
DOI - 10.4414/smw.2022.w30122
Subject(s) - medicine , seroprevalence , population , cross sectional study , confidence interval , demography , epidemiology , socioeconomic status , immunology , antibody , environmental health , serology , pathology , sociology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom